BridgeMD
New treatment option for Cerebral Palsy
Official title Implementation of a HABIT-ILE Intervention at Home for Children With Bilateral Cerebral Palsy
ClinicalTrials.gov ID: NCT05740605
What this study is testing
- What it's testing
- Intensive interventions based on the principles of motor skill learning, like Hand-Arm Bimanual Therapy Including Lower Extremities (HABIT-ILE), have demonstrated excellent effectiveness in improving motor function and daily life independence of children with cerebral palsy (CP). Patients living far from big cities do not have easy access to such interventions, usually applied in the form of camps.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 5 to 18
You may be able to join if
- Children with confirmed diagnosis of bilateral Cerebral Palsy
- Age 5 to 18 years old
- Ability to interact and understand simple instructions in order to complete assessments and therapy
- Availability of a caregiver for 6h30 per day during two weeks of therapy
You likely can't join if
- Uncontrolled seizure
- Botulinum toxin injection in the last 6 months before the first assessment or during the therapy
- Intensive therapy in the last 6 months before the first assessment or during the therapy
- Surgery that could affect the assessments or therapy in the last 6 months before the first assessment or during the therapy
- Severe visual or cognitive impairments interfering with treatment and or assessments
- Any typical contraindication for MRI
The study team makes the final eligibility decision.
Where it's taking place
- Brussels, Belgium
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 5 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Brussels, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.